|
|
|
|
Nutrition Research Division, Food Directorate, Health Products and Food Branch, Health Canada, 2203E Banting Research Centre, Ottawa, Canada K1A 0L2; and Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada
* To whom correspondence should be addressed. E-mail: chaowu_xiao{at}hc-sc.gc.ca.
Epidemiological investigations suggest that soy consumption may be associated with a lower incidence of certain chronic diseases. Clinical studies also show that ingestion of soy proteins reduces the risk factors for cardiovascular disease. This led to the approval of the food-labeling health claim for soy proteins in the prevention of coronary heart disease by the U.S. FDA in 1999. Similar health petitions for soy proteins have also been approved thereafter in the United Kingdom, Brazil, South Africa, the Philippines, Indonesia, Korea, and Malaysia. However, the purported health benefits are quite variable in different studies. The Nutrition Committee of the American Heart Association has assessed 22 randomized trials conducted since 1999 and found that isolated soy protein with isoflavones (ISF) slightly decreased LDL cholesterol but had no effect on HDL cholesterol, triglycerides, lipoprotein(a), or blood pressure. The other effects of soy consumption were not evident. Although the contributing factors to these discrepancies are not fully understood, the source of soybeans and processing procedures of the protein or ISF are believed to be important because of their effects on the content and intactness of certain bioactive protein subunits. Some studies have documented potential safety concerns on increased consumption of soy products. Impacts of soy products on thyroid and reproductive functions as well as on certain types of carcinogenesis require further study in this context. Overall, existing data are inconsistent or inadequate in supporting most of the suggested health benefits of consuming soy protein or ISF.
This article has been cited by other articles:
![]() |
P. J. H. Jones, N.-G. Asp, and P. Silva Proceedings of a symposium held at the Canadian Nutrition Congress. June 21, 2007. Winnipeg, Canada. J. Nutr., June 1, 2008; 138(6): 1189S - 1260S. [Full Text] [PDF] |
||||
![]() |
K. Yamada, N. Sato-Mito, J. Nagata, and K. Umegaki Health Claim Evidence Requirements in Japan J. Nutr., June 1, 2008; 138(6): 1192S - 1198S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang Scientific Substantiation of Functional Food Health Claims in China J. Nutr., June 1, 2008; 138(6): 1199S - 1205S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Tapsell Evidence for Health Claims: A Perspective from the Australia-New Zealand Region J. Nutr., June 1, 2008; 138(6): 1206S - 1209S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-G. Asp and S. Bryngelsson Health Claims in Europe: New Legislation and PASSCLAIM for Substantiation J. Nutr., June 1, 2008; 138(6): 1210S - 1215S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Hasler Health Claims in the United States: An Aid to the Public or a Source of Confusion? J. Nutr., June 1, 2008; 138(6): 1216S - 1220S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. L'Abbe, L. Dumais, E. Chao, and B. Junkins Health Claims on Foods in Canada J. Nutr., June 1, 2008; 138(6): 1221S - 1227S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jew, C. A. Vanstone, J.-M. Antoine, and P. J. H. Jones Generic and Product-Specific Health Claim Processes for Functional Foods across Global Jurisdictions J. Nutr., June 1, 2008; 138(6): 1228S - 1236S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Ames and C. R. Rhymer Issues Surrounding Health Claims for Barley J. Nutr., June 1, 2008; 138(6): 1237S - 1243S. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Farnworth The Evidence to Support Health Claims for Probiotics J. Nutr., June 1, 2008; 138(6): 1250S - 1254S. [Abstract] [Full Text] [PDF] |
||||